CLOROX CO /DE/
CLOROX CO /DE/ (CLX) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
• Clorox is a portfolio of category-leading household brands across health and wellness, household, and lifestyle lines, the kind of business whose value rests on shelf position and pricing power rather than on growth. • The defining near-term distortion is the ERP system transition, which management expects to cut roughly 7.5 percentage points off fiscal 2026 net sales and weigh about $0.90 on EPS as retailers worked down inventory [Source: Q3 FY2026 results and outlook]. • The risk to watch is
Is CLX overvalued? See what's priced in →
1,051 institutional managers reported holding CLX in 13F filings for the quarter ended 2026-03-31. Together they hold about 81% of the company; the top 10 hold 43%. 139 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 11.5M shares were sold short as of the 2026-06-15 count, about 9% of shares outstanding (4.5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CLX has cut its share count 1.3% over the past five years, spending $613.00M on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 17 years straight; the current rate is $4.88 a share annually. Cash returned over the past three years: $1.65B in dividends and $588.00M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CLX over the trailing three years: 2025: 2 buys totaling $963k. 14 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CLX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-11 | +9.5% | -23.9% |
| 2023-11-02 | +4.5% | +15.9% |
| 2024-02-02 | +7.6% | -6.7% |
| 2024-05-01 | -6.1% | -5.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CLX's latest 8-K filings: 2026-06-17 (items 5.02, 7.01, 9.01); 2026-05-28 (items 5.02, 7.01, 9.01); 2026-05-11 (items 8.01, 9.01); 2026-04-30 (items 2.02, 7.01, 9.01); 2026-04-01 (items 7.01, 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.